Original Research
Accepted on 26 Apr 2024
Identification of cytokines in benign and malignant thymus tumors: based on Mendelian randomization and Proteomics
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1390140
Type at least 3 characters
1,109 articles
Articles
Original Research
Accepted on 24 Apr 2024
Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1365321
Original Research
Published on 24 Apr 2024
Genetic changes in the FH gene cause vagal paraganglioma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1381093
- 194 views
Editorial
Published on 23 Apr 2024
Editorial: Resistance to endocrine therapies in cancer, volume II
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1414392
Case Report
Accepted on 22 Apr 2024
Case Report: Secondary Failure to Tolvaptan in a Patient with SCLC and Paraneoplastic SIADH
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1382066
Original Research
Accepted on 22 Apr 2024
Causal associations between platelet count, alcohol consumption, and the risk of liver hepatocellular carcinoma based on a Mendelian randomization study
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1400573
Editorial
Accepted on 17 Apr 2024
Editorial: Altered Metabolic Traits in Gastro-intestinal Tract Cancers
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1390877
Original Research
Published on 17 Apr 2024
Elevated sortilin expression discriminates functional from non-functional neuroendocrine tumors and enables therapeutic targeting
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1331231
- 286 views
Original Research
Accepted on 16 Apr 2024
Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1217495
Original Research
Published on 15 Apr 2024
Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1306091
- 182 views
Original Research
Published on 15 Apr 2024
Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1253832
- 185 views
Original Research
Accepted on 12 Apr 2024
Patterns of Distant Metastasis and Survival Outcomes in de novo Metastatic Breast Cancer According to Age Groups
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1385756
- 128 views
Original Research
Published on 12 Apr 2024
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1369268
- 306 views
Original Research
Published on 11 Apr 2024
Vascular complications in craniopharyngioma-resected paediatric patients: a single-center experience
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1292025
- 190 views
Editorial
Published on 05 Apr 2024
Editorial: New molecular pathways in thyroid cancer and pathophysiology: role of coding and noncoding genes
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1404305
- 289 views
Systematic Review
Published on 05 Apr 2024
Outcomes of endoscopic ultrasound-guided ablation and minimally invasive surgery in the treatment of pancreatic insulinoma: a systematic review and meta-analysis
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1367068
- 416 views